Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $375,860 | 122 | 99.5% |
| Travel and Lodging | $1,254 | 7 | 0.3% |
| Food and Beverage | $689.44 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $142,500 | 17 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $111,908 | 77 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $89,750 | 12 | $0 (2022) |
| ViiV Healthcare Company | $15,058 | 14 | $0 (2018) |
| Optinose US, Inc. | $13,750 | 9 | $0 (2021) |
| VERTEX PHARMACEUTICALS INCORPORATED | $4,836 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,475 | 3 | E.R. Squibb & Sons, L.L.C. ($2,475) |
| 2022 | $131,031 | 35 | Biohaven Pharmaceutical Holding Company Ltd. ($89,750) |
| 2021 | $204,879 | 62 | Biohaven Pharmaceuticals, Inc. ($139,000) |
| 2020 | $19,523 | 15 | E.R. Squibb & Sons, L.L.C. ($8,048) |
| 2019 | $4,836 | 9 | VERTEX PHARMACEUTICALS INCORPORATED ($4,836) |
| 2018 | $15,058 | 14 | ViiV Healthcare Company ($15,058) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/17/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 02/10/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 01/13/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| 12/23/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 12/23/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 12/16/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 12/09/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 11/25/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 11/18/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 11/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $7,250.00 | General |
| 11/10/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,451.52 | General |
| 11/04/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| 10/28/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,653.13 | General |
| 10/21/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 10/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 10/14/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,451.52 | General |
| 10/07/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 09/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 08/16/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| 07/18/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 06/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $8,500.00 | General |
| 05/17/2022 | Biohaven Pharmaceutical Holding Company Ltd. | — | Consulting Fee | Cash or cash equivalent | $7,000.00 | General |
| 05/13/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 05/06/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $275.00 | General |
| 04/22/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $412.50 | General |
About Dr. Steven Schnittman, M.D
Dr. Steven Schnittman, M.D is a Infectious Disease healthcare provider based in West Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669560124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Schnittman, M.D has received a total of $377,803 in payments from pharmaceutical and medical device companies, with $2,475 received in 2023. These payments were reported across 138 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($375,860).
Practice Information
- Specialty Infectious Disease
- Location West Haven, CT
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1669560124
Products in Payments
- Xhance (Drug) $13,750
- NURTEC ODT (Drug) $7,250
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in West Haven
Dr. Kalpana Gupta, Md, MD
Infectious Disease — Payments: $118,878
Richard Sutton, Md, MD
Infectious Disease — Payments: $33,285
Dr. Shaili Gupta, Md, MD
Infectious Disease — Payments: $13.77
Dr. Ann Fisher, Md, MD
Infectious Disease